Discontinued — last reported Q3 '25
Idexx Laboratories Common shares outstanding (in shares) increased by 1.7% to 60K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from 59K to 60K. Over 5 years (FY 2020 to FY 2025), Common shares outstanding (in shares) shows a downward trend with a -7.5% CAGR.
other_common_stock_other_shares_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 90K | 90K | 90K | 90K | 58K | 58K | 58K | 58K | 59K | 59K | 59K | 59K | 60K | 60K | 60K | 59K | 60K | 60K | 59K | 60K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -35.6% | +0.0% | +0.0% | +0.0% | +1.7% | +0.0% | +0.0% | +0.0% | +1.7% | +0.0% | +0.0% | -1.7% | +1.7% | +0.0% | -1.7% | +1.7% |
| YoY Change | — | — | — | — | -35.6% | -35.6% | -35.6% | -35.6% | +1.7% | +1.7% | +1.7% | +1.7% | +1.7% | +1.7% | +1.7% | +0.0% | +0.0% | +0.0% | -1.7% | +1.7% |